Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.
Open Access
- 1 December 1994
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 180 (6) , 2353-2358
- https://doi.org/10.1084/jem.180.6.2353
Abstract
We describe here a new method for predicting class II major histocompatibility complex-binding peptides, based on the preferences observed in a systematic series of peptide binding experiments where each position in a "minimal" peptide was replaced individually by every amino acid. The DRB1*0401 peptide binding preferences were determined and incorporated into a computer program that looks through sequences for potential epitopes and assigns each a score. These scores correlate well with previously determined T cell epitopes of foreign antigens and endogenous peptides from self proteins. Our findings hold implications for the design of subunit vaccines and in the identification of autoantigenic peptide regions within self proteins.Keywords
This publication has 15 references indexed in Scilit:
- High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.Proceedings of the National Academy of Sciences, 1994
- Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103).The Journal of Immunology, 1994
- Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptideNature, 1994
- MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activationCell, 1994
- HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.The Journal of Immunology, 1993
- Promiscuous and allele-specific anchors in HLA-DR-binding peptidesCell, 1993
- Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.Journal of Clinical Investigation, 1993
- [19] Selection of T cell epitopes and vaccine engineeringPublished by Elsevier ,1991
- A Molecular Basis for MHC Class II—Associated AutoimmunityScience, 1988
- Prediction of immunodominant helper T cell antigenic sites from the primary sequence.The Journal of Immunology, 1987